Buy Adbry (tralokinumab-ldrm) Online

5.00 out of 5

  • DISEASE INDICATIONS: Atopic Dermatitis
  • MANUFACTURER: Leo Pharma
  • USAGE: Subcutaneous
  • MEDICINE APPROVED BY:
  • Food and Drug Administration (FDA)
Adbry is a prescription medication used to treat moderate to severe atopic dermatitis in adults by inhibiting the action of the Interleukin-13 protein. It is administered via subcutaneous injection every two weeks and is not recommended for use in children under 18. The recommended dosage is 150mg, and Adbry should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F).

$1,299.00
Select optionsThis product has multiple variants. The options may be chosen on the product page

Buy Cibinqo (abrocitinib) Online

5.00 out of 5

DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Pfizer Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Medicines & Healthcare products Regulatory Agency (MHRA) Cibinqo (abrocitinib) is a tablet taken orally once daily to treat moderate to severe atopic dermatitis in adults and children aged 12 years and older who have not responded well to topical treatments. This medication blocks certain enzymes that cause inflammation and works as a Janus kinase (JAK) inhibitor.

From $1,322.20
Select optionsThis product has multiple variants. The options may be chosen on the product page

Buy Ilumya (tildrakizumab) Online

0 out of 5

DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is an injection medication used to treat moderate to severe plaque psoriasis in adults.

Read more
, ,

Buy Olumiant (baricitinib) Online

4.67 out of 5

DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is an oral medication used to treat rheumatoid arthritis in adults who have not responded well to other medications.

From $1,098.90
Select optionsThis product has multiple variants. The options may be chosen on the product page

Buy Skilarence (dimethyl fumarate) Online

4.80 out of 5

DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Skilarence (dimethyl fumarate) is an oral medication prescribed to treat relapsing-remitting multiple sclerosis in adults. The drug works by activating a protein known as the Nrf2 pathway, which helps reduce inflammation and protect against nerve damage.

From $95.70
Select optionsThis product has multiple variants. The options may be chosen on the product page
,

Buy Skyrizi (Risankizumab) Online

5.00 out of 5

  • DISEASE INDICATIONS: Psoriasis
  • MANUFACTURER: AbbVie Ltd
  • USAGE: Subcutaneous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Therapeutic Goods Administration (TGA)
Skyrizi (risankizumab) is a prescription medication for moderate to severe plaque psoriasis in adults. Administered via subcutaneous injection, Skyrizi improves the patient's quality of life by reducing scaly and itchy patches on the skin and slowing down the progression of the disease.

From $14,905.00
Select optionsThis product has multiple variants. The options may be chosen on the product page

Buy Spevigo (spesolimab-sbzo) Online

0 out of 5

DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication administered through intravenous infusion to treat moderate to severe plaque psoriasis in adults. The medication blocks the protein interleukin-23 (IL-23) to reduce inflammation, improve skin appearance, and slow down disease progression.

Read more

Buy Takhzyro (lanadelumab) Online

0 out of 5

  • DISEASE INDICATIONS: Hereditary angioedema (HAE)
  • MANUFACTURER: Shire Pharmaceuticals
  • USAGE: Subcutaneous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
Takhzyro (lanadelumab) is a human monoclonal antibody that is used to prevent attacks of hereditary angioedema (HAE) in adults and children aged 2 years and older. HAE is a rare genetic disorder that causes swelling in the face, limbs, abdomen, and throat.

$14,430.90
Select optionsThis product has multiple variants. The options may be chosen on the product page
,

Buy Taltz (ixekizumab) Online

0 out of 5

  • DISEASE INDICATIONS: Psoriasis
  • MANUFACTURER: Eli Lilly Nederland B.V.
  • USAGE: Subcutaneous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • Therapeutic Goods Administration (TGA)
Taltz (ixekizumab) is a humanized monoclonal antibody that is used to treat moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis in adults.

From $2,566.30
Select optionsThis product has multiple variants. The options may be chosen on the product page

Buy Zoryve (roflumilast) Online

0 out of 5

  • DISEASE INDICATIONS: Psoriasis
  • MANUFACTURER: Arcutis Biotherapeutics, Inc.
  • USAGE: Cutaneous
  • MEDICINE APPROVED BY:
  • Food and Drug Administration (FDA)
Zoryve (roflumilast) is a topical cream that is used to treat plaque psoriasis of the skin and skin folds in adults and children aged 12 years and older. Plaque psoriasis is a chronic autoimmune disease that causes red, scaly patches to form on the skin.

$1,053.80
Select optionsThis product has multiple variants. The options may be chosen on the product page